Glaesner, Wolfgang <br/><br/>
Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein.  [electronic resource] 

 -  Diabetes/metabolism research and reviews  May 2010 
 - 287-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1520-7560 
<br/><br/><label>Standard No.: </label>10.1002/dmrr.1080  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Genes, Reporter<br/>Glucagon-Like Peptide-1 Receptor<br/>Glucagon-Like Peptides--analogs & derivatives<br/>Humans<br/>Immunoglobulin Fc Fragments--genetics<br/>Incretins--genetics<br/>Insulin--metabolism<br/>Insulin Secretion<br/>Islets of Langerhans--metabolism<br/>Macaca fascicularis<br/>Membrane Proteins--genetics<br/>Mice<br/>Mitochondrial Proteins--genetics<br/>Protein Engineering<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Glucagon--agonists<br/>Recombinant Fusion Proteins--genetics<br/>beta-Lactamases--genetics